PT  - JOURNAL ARTICLE
AU  - Gertjan Medema
AU  - Leo Heijnen
AU  - Goffe Elsinga
AU  - Ronald Italiaander
AU  - Anke Brouwer
TI  - Presence of SARS-Coronavirus-2 in sewage
AID  - 10.1101/2020.03.29.20045880
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.29.20045880
4099  - http://medrxiv.org/content/early/2020/07/25/2020.03.29.20045880.short
4100  - http://medrxiv.org/content/early/2020/07/25/2020.03.29.20045880.full
AB  - In the current COVID-19 pandemic, a significant proportion of cases shed SARS-Coronavirus-2 (SARS-CoV-2) with their faeces. To determine if SARS-CoV-2 is present in sewage during the emergence of COVID-19 in the Netherlands, sewage samples of 7 cities and the airport were tested using RT-PCR against three fragments of the nucleocapsid protein gene (N1-3) and one fragment of the envelope protein gene (E). No SARS-CoV-2 was detected in samples of February 6, three weeks before the first case was reported in the Netherlands on February 27. On March 5, the N1 fragment was detected in sewage of five sites. On March 15/16, the N1 fragment was detected in sewage of six sites, and the N3 and E fragment were detected at 5 and 4 sites respectively. This is the first report of detection of SARS-CoV-2 in sewage. The detection of the virus in sewage, even when the COVID-19 prevalence is low, indicates that sewage surveillance could be a sensitive tool to monitor the circulation of the virus in the population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research was funded entirely by KWR Water Research Institute, no external funds were received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and methods are reported in the manuscript